4/15
09:18 pm
coll
Collegium Pharmaceutical Sets 2026 Revenue Outlook, Details $650M AZSTARYS Deal at Needham Conference [Yahoo! Finance]
Medium
Report
Collegium Pharmaceutical Sets 2026 Revenue Outlook, Details $650M AZSTARYS Deal at Needham Conference [Yahoo! Finance]
4/8
08:00 am
coll
Collegium to Participate in Upcoming Investor Conferences
Low
Report
Collegium to Participate in Upcoming Investor Conferences
4/6
06:35 am
coll
1 Value Stock on Our Buy List and 2 Facing Headwinds [Yahoo! Finance]
Low
Report
1 Value Stock on Our Buy List and 2 Facing Headwinds [Yahoo! Finance]
4/2
08:52 am
coll
2 Profitable Stocks to Consider Right Now and 1 We Question [Yahoo! Finance]
Low
Report
2 Profitable Stocks to Consider Right Now and 1 We Question [Yahoo! Finance]
3/31
07:40 am
coll
Is Collegium Pharmaceutical (COLL) One of the Best Small-Cap Drug Manufacturers [Yahoo! Finance]
Low
Report
Is Collegium Pharmaceutical (COLL) One of the Best Small-Cap Drug Manufacturers [Yahoo! Finance]
3/30
09:36 pm
coll
Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD [Yahoo! Finance]
Low
Report
Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD [Yahoo! Finance]
3/26
04:44 am
coll
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL) [Yahoo! Finance]
Low
Report
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL) [Yahoo! Finance]
3/20
08:05 am
coll
Collegium Pharmaceutical (COLL) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $56.00 price target on the stock, up from $54.00.
Low
Report
Collegium Pharmaceutical (COLL) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $56.00 price target on the stock, up from $54.00.
3/20
08:05 am
coll
Collegium Pharmaceutical (COLL) had its "buy" rating reaffirmed by HC Wainwright. They now have a $60.00 price target on the stock.
Low
Report
Collegium Pharmaceutical (COLL) had its "buy" rating reaffirmed by HC Wainwright. They now have a $60.00 price target on the stock.
3/19
07:41 pm
coll
Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript [Seeking Alpha]
Low
Report
Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript [Seeking Alpha]
3/19
10:02 am
coll
Collegium Pharmaceutical to Buy AZSTARYS for $650M, Expanding ADHD Franchise Through 2037 [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical to Buy AZSTARYS for $650M, Expanding ADHD Franchise Through 2037 [Yahoo! Finance]
3/19
08:00 am
coll
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
Low
Report
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
3/14
08:12 pm
coll
Collegium Pharmaceutical touts record 2025, sees JORNAY PM driving 2026 growth at Barclays Miami Conference [Yahoo! Finance]
Medium
Report
Collegium Pharmaceutical touts record 2025, sees JORNAY PM driving 2026 growth at Barclays Miami Conference [Yahoo! Finance]
3/14
08:12 pm
coll
A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Pressure [Yahoo! Finance]
Medium
Report
A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Pressure [Yahoo! Finance]
3/10
09:14 am
coll
Collegium Pharmaceutical (COLL) Surged Following Record Quarterly Results [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical (COLL) Surged Following Record Quarterly Results [Yahoo! Finance]
3/6
06:10 pm
coll
Collegium Pharmaceutical (COLL) was downgraded by
Weiss Ratings from "buy (b-)" to "hold (c+)".
Low
Report
Collegium Pharmaceutical (COLL) was downgraded by
Weiss Ratings from "buy (b-)" to "hold (c+)".
3/5
08:00 am
coll
Collegium to Present New Real-World Data at PainConnect 2026
Medium
Report
Collegium to Present New Real-World Data at PainConnect 2026
3/3
08:47 am
coll
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community [Yahoo! Finance]
Medium
Report
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community [Yahoo! Finance]
3/3
08:00 am
coll
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
Medium
Report
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
3/2
08:00 am
coll
Collegium to Participate in Upcoming Investor Conferences
Low
Report
Collegium to Participate in Upcoming Investor Conferences
2/28
12:43 am
coll
Why Collegium Pharmaceutical (COLL) Is Down 7.4% After Reaffirming 2026 Revenue Guidance Despite Earnings Miss [Yahoo! Finance]
Low
Report
Why Collegium Pharmaceutical (COLL) Is Down 7.4% After Reaffirming 2026 Revenue Guidance Despite Earnings Miss [Yahoo! Finance]
2/27
05:32 pm
coll
Why Collegium Pharmaceutical (COLL) Stock Is Trading Lower Today [Yahoo! Finance]
Low
Report
Why Collegium Pharmaceutical (COLL) Stock Is Trading Lower Today [Yahoo! Finance]
2/26
04:50 pm
coll
Collegium Pharmaceutical, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
Collegium Pharmaceutical, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/26
03:26 pm
coll
Collegium (COLL) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Collegium (COLL) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/26
02:28 pm
coll
Collegium Pharmaceutical (COLL) had its price target lowered by Needham & Company LLC from $56.00 to $54.00. They now have a "buy" rating on the stock.
Low
Report
Collegium Pharmaceutical (COLL) had its price target lowered by Needham & Company LLC from $56.00 to $54.00. They now have a "buy" rating on the stock.